AroundImagine if the tables were turned around . First TLT signs a JV then , shortly after and because the SP exploded to $3.00 , TLT does a PP by selling 4 million units at $2.50 ( each unit consist of one share and a half of a purchase warrant ) .
CAPITAL FUNDING
-upfront payment from JV deal 5 - 10 million
-milestone payment for FDA approval
of Ph2 NMIBC trial 10 - 20 million
-PP funding 10 million
-share purchase through
warrants exercised at 37.5 cents 3 - 4 million
-share purchase through
warrants exercised at 54 cents 9 - 10 million
TOTAL 37 - 54 million
CAPITAL EXPENSES ( next 2 years )
-Ph2 NMIBC 10 - 20 million
-Ph1 LUNG 5 - 10 million
-Ph1 GBM 5 - 10 million
-pre clinical research 5 - 10 million
-salaries and other expenses 5 - 10 million
TOTAL 30 - 60 million
P.S. There is also a milestone payment of 500 - 700 million plus royalties upon FDA approval for commercialization of the drug TLD-1433 and associated treatment procedures.
In 18 - 30 months all this could lead to a $15.00 - $40.00 SP or a higher buyout
GO TLT GO
GO AM GO
GO JV GO
HAPPY WEDNESDAY